Macroglobulin

Cyclerion Therapeutics Reports Full Year 2020 Financial Results and Corporate Update

Retrieved on: 
Thursday, February 25, 2021
Branches of biology, Medicine, Health sciences, A2M, Biomarkers, alpha-2-Macroglobulin, Clinical trial, Cash and cash equivalents, Macroglobulin, Complement component 3

CY6463 administration resulted in improvement in the levels of various neuroinflammatory biomarkers, including alpha-2-macroglobulin (A2M) and Complement C3 (C3).

Key Points: 
  • CY6463 administration resulted in improvement in the levels of various neuroinflammatory biomarkers, including alpha-2-macroglobulin (A2M) and Complement C3 (C3).
  • ADv Clinical Trial Initiation: The Company anticipates initiating a 12-week Phase 2a clinical trial in patients with ADv midyear.
  • Cash Position:Cash, cash equivalents, and restricted cash balance onDecember 31, 2020 was approximately$58 million, as compared toapproximately$71milliononSeptember 30, 2020.
  • For more information about Cyclerion, please visit https://www.cyclerion.com/ and follow us on Twitter (@Cyclerion) and LinkedIn ( www.linkedin.com/company/cyclerion ).

CAREstream Group and Cytonics Corporation Agree to Global License Collaboration

Retrieved on: 
Tuesday, June 9, 2020
A2M, alpha-2-Macroglobulin, Blood proteins, Macroglobulin

To this end, we are thrilled to partner with CAREstream America to market and distribute the APIC technology on a global scale, bringing affordable relief to patients around the world.

Key Points: 
  • To this end, we are thrilled to partner with CAREstream America to market and distribute the APIC technology on a global scale, bringing affordable relief to patients around the world.
  • Cytonics' APICTM system concentrates and purifies the Alpha-2-Macroglobulin (A2M) molecule from patients' blood, producing a therapeutic composition that is injected into damaged joints.
  • The CAREstream group is dedicated to bettering the lives of its employees, patients and customers through premium services and products.
  • Axiom Therapies, Christie Medical Holdings Inc. and MedPro Respiratory are also elements of the CAREstream Group.